We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002926:SZSEHUAXI Securities Co., Ltd. Class A Analysis

Data as of 2026-03-15 - not real-time

CN¥8.76

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

HUAXI Securities trades at 8.76 CNY, dramatically below its DCF fair value of 78.87 CNY, implying a material valuation gap. The stock’s PE ratio of 15.1 is slightly under the industry average of 16.4, while its price‑to‑book of 0.94 suggests it is priced below book value. Profitability is exceptional, with a gross margin of 92%, operating margin of 48% and a net profit margin of 30%, supported by a robust revenue growth of 66%. The balance sheet shows ample liquidity, with cash of 69.1 bn CNY far exceeding debt of 46.3 bn CNY, though the debt‑to‑equity ratio is high at 190%. Technical indicators reveal a bearish price trend—price is under the 20‑day (8.87), 50‑day (9.11) and 200‑day (9.48) SMAs—but the MACD line has turned bullish and the RSI sits near 40, hinting at possible short‑term relief. Volume is increasing, and the stock currently holds above its nearest support at 8.60 CNY, while resistance sits near 9.11 CNY. The low beta (~0.18) and moderate 30‑day volatility (≈15%) suggest limited market‑wide price swings.
Given the deep valuation discount, strong earnings profile, and modest dividend yield of 1.43% with a low payout ratio, the fundamentals support a buy case, especially for investors with a medium‑to‑long horizon. However, the high leverage and regulatory environment in China’s capital‑markets add a layer of caution, making a phased entry around support levels prudent.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD crossover with positive histogram
  • RSI approaching oversold territory (~40)
  • Price holding above key support at 8.60 CNY

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Substantial valuation gap vs DCF fair value
  • Strong profitability margins and 66% revenue growth
  • Attractive valuation multiples (PE below industry, P/B < 1)

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential regulatory headwinds in China’s securities sector
  • High debt‑to‑equity ratio despite ample cash reserves
  • Sustainable dividend yield with low payout ratio

Key Metrics & Analysis

Financial Health

Revenue Growth66.20%
Profit Margin29.71%
P/E Ratio15.1
ROE6.46%
ROA1.47%
Debt/Equity189.66
P/B Ratio0.9
Op. Cash FlowCN¥7.1B
Industry P/E16.4

Technical Analysis

TrendBearish
RSI40.0
SupportCN¥8.60
ResistanceCN¥9.11
MA 20CN¥8.87
MA 50CN¥9.11
MA 200CN¥9.48
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueCN¥78.87
Target PriceCN¥12.20
Upside/Downside39.27%
GradeUndervalued
TypeValue
Dividend Yield1.43%

Risk Assessment

Beta0.18
Volatility14.92%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.